Prior to testing 64Cu-NOTA-bevacizumab PET therapeutic response imaging, a cohort of mice was treated daily with RAD001, 10 mg/kg, or vehicle, to determine the rapalog’s effect on tumor mTOR signaling and VEGF content. The gene discussed is MTOR; the disease is neoplasm.